Atlas Lithium (NASDAQ: ATLX)

$3.21+1.90%today

Brazilian ADR trading on the NASDAQ, priced in US dollars.

Market Cap: $94.67M
P/E (TTM): —
P/B: 2.0x
EPS (TTM): $-1.49
Dividend Yield: —
52-Week Range: $2.55 – $8.25
Volume: 114K
Previous Close: $3.15

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

+1.90%

1 Week

+0.63%

1 Month

+5.59%

YTD

-24.11%

1 Year

-45.96%

5 Years

-57.20%

About Atlas Lithium

US Ticker: ATLX
B3 Ticker: —
Exchange: NASDAQ
Currency: USD
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
Headquarters: Belo Horizonte, MG, Brazil
Employees: 64
CEO: Dr. Marc Fogassa M.D.
Founded: 2011

Atlas Lithium Corporation operates as a mineral exploration and development company in Brazil.

It operates the Minas Gerais Lithium project that consists of 85 mineral rights covering an area of 468 square kilometers located in northeastern Minas Gerais, Brazil; and Northeastern Brazil Lithium project covering an area of 71 square kilometers located in the States of Paraíba, Rio Grande do Norte, and Tocantins.

The company is also involved in the exploration and development of mineral rights relating to minerals, such as rare earths, copper, titanium, graphite, nickel, iron, gold, and quartzite.

The company was formerly known as Brazil Minerals, Inc. and changed its name to Atlas Lithium Corporation in October 2022.

Atlas Lithium Corporation was founded in 2011 and is based in Belo Horizonte, Brazil.

www.atlas-lithium.com

Analyst Ratings

Consensus of 1 Wall Street analyst · sourced from Yahoo Finance

None

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$12.50

Average

$12.50

High

$12.50

The average target is +289.41% above the current price of $3.21.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Atlas Lithium's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Solid

Net Margin: -23042.0%
ROE: -71.9%
Rev Growth (YoY): +53.21%
Net Debt / EBITDA: 0.62×
Current Ratio: 2.52×
Interest Coverage: —
Free Cash Flow: -34.5M
Payout Ratio: —

Income — Margins & Efficiency

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011
Revenue	$141,702	+53.2%	$92,491	-86.1%	$667,131	+107501.8%	$620	-90.8%	$6,765	-33.9%	$10,232	-56.4%	$23,446	+52.3%	$15,393	-21.9%	$19,716	-54.4%	$43,253	+224.6%	$13,323	-79.1%	$63,610	-87.1%	$492,129	-37.8%	$791,780	—	—	—	—
Gross profit	$23,226	+139.1%	-$59,431	-122.4%	$265,694	+1166.1%	-$24,923	-70.0%	-$14,659	+93.8%	-$235,578	-121.2%	-$106,497	+36.1%	-$166,775	-56.6%	-$106,501	+35.7%	-$165,587	+19.2%	-$204,922	-105.9%	-$99,539	-318.7%	$45,523	-86.7%	$342,950	—	—	—	—
Operating income	-$38,647,249	-22.1%	-$31,651,704	+27.8%	-$43,858,245	-4.2%	-$42,106,732	-618.4%	-$5,861,020	-66.7%	-$3,516,092	-174.4%	-$1,281,553	-1.4%	-$1,264,344	-9.1%	-$1,159,331	+16.2%	-$1,382,804	-4.6%	-$1,322,621	-3.1%	-$1,282,796	+30.9%	-$1,856,038	+23.1%	-$2,412,956	-1480.7%	-$152,655	+16.6%	-$183,000
EBITDA	-$37,869,954	-19.2%	-$31,782,744	+28.3%	-$44,350,434	-5.7%	-$41,965,093	-612.3%	-$5,891,146	-57.7%	-$3,734,538	-248.7%	-$1,070,957	+15.5%	-$1,267,675	-16.9%	-$1,083,985	+16.2%	-$1,294,303	-9.6%	-$1,180,563	-79.1%	-$658,994	+74.4%	-$2,573,104	-6.7%	-$2,412,053	-1480.1%	-$152,655	-183.3%	$183,186
Net profit	-$32,651,043	-16.2%	-$28,110,592	+33.5%	-$42,241,196	-3.6%	-$40,768,275	-726.6%	-$4,931,755	-77.9%	-$2,772,358	-142.8%	-$1,141,663	+38.7%	-$1,862,077	-11.8%	-$1,666,200	+1.5%	-$1,691,433	-6.5%	-$1,588,418	+15.4%	-$1,878,268	+45.3%	-$3,436,643	-54.9%	-$2,218,873	-1171.8%	-$174,463	—	—
Gross margin	16.4%	+80.6 p.p.	-64.3%	-104.1 p.p.	39.8%	+4059.7 p.p.	-4019.8%	-3803.1 p.p.	-216.7%	+2085.7 p.p.	-2302.4%	-1848.1 p.p.	-454.2%	+629.2 p.p.	-1083.4%	-543.3 p.p.	-540.2%	-157.3 p.p.	-382.8%	+1155.3 p.p.	-1538.1%	-1381.6 p.p.	-156.5%	-165.7 p.p.	9.3%	-34.1 p.p.	43.3%	—	—	—	—
Operating margin	-27273.6%	+6947.8 p.p.	-34221.4%	-27647.2 p.p.	-6574.2%	+6784834.2 p.p.	-6791408.4%	-6704771.0 p.p.	-86637.4%	-52273.7 p.p.	-34363.7%	-28897.7 p.p.	-5466.0%	+2747.8 p.p.	-8213.8%	-2333.6 p.p.	-5880.2%	-2683.1 p.p.	-3197.0%	+6730.3 p.p.	-9927.4%	-7910.7 p.p.	-2016.7%	-1639.5 p.p.	-377.1%	-72.4 p.p.	-304.8%	—	—	—	—
EBITDA margin	-26725.1%	+7638.0 p.p.	-34363.1%	-27715.1 p.p.	-6647.9%	+6761915.5 p.p.	-6768563.4%	-6681480.7 p.p.	-87082.7%	-50584.1 p.p.	-36498.6%	-31930.9 p.p.	-4567.8%	+3667.6 p.p.	-8235.4%	-2737.4 p.p.	-5498.0%	-2505.6 p.p.	-2992.4%	+5868.7 p.p.	-8861.1%	-7825.1 p.p.	-1036.0%	-513.1 p.p.	-522.9%	-218.2 p.p.	-304.6%	—	—	—	—
Net margin	-23042.0%	+7350.7 p.p.	-30392.8%	-24061.0 p.p.	-6331.8%	+6569196.5 p.p.	-6575528.2%	-6502627.2 p.p.	-72901.0%	-45806.1 p.p.	-27095.0%	-22225.6 p.p.	-4869.3%	+7227.6 p.p.	-12096.9%	-3645.9 p.p.	-8451.0%	-4540.4 p.p.	-3910.6%	+8011.8 p.p.	-11922.4%	-8969.6 p.p.	-2952.8%	-2254.5 p.p.	-698.3%	-418.1 p.p.	-280.2%	—	—	—	—
Revenue growth (YoY)	53.2%	+139.3 p.p.	-86.1%	-107587.9 p.p.	107501.8%	+107592.6 p.p.	-90.8%	-57.0 p.p.	-33.9%	+22.5 p.p.	-56.4%	-108.7 p.p.	52.3%	+74.2 p.p.	-21.9%	+32.5 p.p.	-54.4%	-279.1 p.p.	224.6%	+303.7 p.p.	-79.1%	+8.0 p.p.	-87.1%	-49.2 p.p.	-37.8%	—	—	—	—	—	—
Effective tax rate	—	—	11.9%	+11.9 p.p.	-0.0%	-2954.1 p.p.	2954.0%	+2937.0 p.p.	17.0%	-7.8 p.p.	24.8%	+21.4 p.p.	3.4%	+28.9 p.p.	-25.5%	-35.3 p.p.	9.8%	+26.0 p.p.	-16.2%	-10.7 p.p.	-5.4%	-1.4 p.p.	-4.1%	-3.3 p.p.	-0.8%	-9.6 p.p.	8.7%	+23.0 p.p.	-14.3%	-114.3 p.p.	100.0%
Interest coverage	—	—	-44.47×	—	—	—	—	—	-37.90×	-154.8%	-14.87×	-468.1%	-2.62×	-48.4%	-1.76×	-4.9%	-1.68×	+38.5%	-2.73×	-1.8%	-2.69×	-336.6%	-0.62×	+80.2%	-3.11×	+97.1%	-106.56×	—	—	—	—

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011
Net debt	-$23,600,928	+6.8%	-$25,323,104	-386.9%	-$5,200,457	+73.2%	-$19,420,443	-7397.3%	-$259,032	-1954.3%	-$12,609	-100.9%	$1,421,173	+5.0%	$1,353,127	+23.9%	$1,092,537	+88.0%	$581,287	+70.0%	$341,891	-37.1%	$543,482	-22.1%	$697,496	+1690.7%	-$43,849	+94.9%	-$863,089	-3916.6%	-$21,488
Net Debt / Equity	-0.52×	-6.6%	-0.49×	-99.3%	-0.24×	+90.9%	-2.68×	-1654.9%	-0.15×	-1425.4%	0.01×	+102.8%	-0.41×	+16.3%	-0.49×	-18.3%	-0.41×	-35.9%	-0.30×	-19.1%	-0.26×	+75.6%	-1.05×	-194.7%	-0.36×	-112.0%	-0.17×	+69.0%	-0.54×	+56.0%	-1.23×
Net Debt / EBITDA	0.62×	-21.8%	0.80×	+579.5%	0.12×	-74.7%	0.46×	+952.5%	0.04×	+1202.3%	0.00×	+100.3%	-1.33×	-24.3%	-1.07×	-5.9%	-1.01×	-124.4%	-0.45×	-55.1%	-0.29×	+64.9%	-0.82×	-204.2%	-0.27×	-1591.1%	0.02×	-99.7%	5.65×	+4919.9%	-0.12×
Debt / Equity	0.24×	+15.9%	0.20×	-58.0%	0.49×	-65.2%	1.40×	+10931.3%	0.01×	+236.4%	-0.01×	+98.1%	-0.48×	+11.3%	-0.54×	-31.2%	-0.41×	-19.0%	-0.35×	-33.6%	-0.26×	+77.7%	-1.17×	-220.5%	-0.37×	-243.9%	0.25×	+405320.0%	0.00×	—	—
Current ratio	2.52×	-1.4%	2.56×	-10.4%	2.86×	-43.3%	5.03×	+3976.2%	0.12×	+112.8%	0.06×	-55.8%	0.13×	+45.8%	0.09×	+194.7%	0.03×	-68.3%	0.10×	-21.3%	0.12×	-34.5%	0.19×	+6.2%	0.18×	-87.7%	1.43×	-88.9%	12.80×	+138.2%	5.37×
Return on equity (ROE)	-71.9%	-17.8 p.p.	-54.1%	+144.6 p.p.	-198.7%	+363.8 p.p.	-562.5%	-271.8 p.p.	-290.7%	-544.0 p.p.	253.3%	+220.4 p.p.	32.9%	-34.4 p.p.	67.3%	+4.3 p.p.	63.0%	-25.5 p.p.	88.5%	-30.1 p.p.	118.6%	-243.3 p.p.	361.9%	+186.8 p.p.	175.1%	+1023.7 p.p.	-848.5%	-837.6 p.p.	-10.9%	—	—
Return on assets (ROA)	-37.3%	-5.3 p.p.	-32.1%	+41.0 p.p.	-73.0%	+20.5 p.p.	-93.6%	-6.8 p.p.	-86.8%	+90.5 p.p.	-177.2%	-57.3 p.p.	-119.9%	+61.5 p.p.	-181.4%	-12.7 p.p.	-168.8%	-37.8 p.p.	-131.0%	+4.4 p.p.	-135.3%	+30.5 p.p.	-165.8%	+88.7 p.p.	-254.5%	-10.7 p.p.	-243.8%	-233.3 p.p.	-10.5%	—	—
Book value / share	$1.67	-41.5%	$2.85	+94.8%	$1.46	+103.2%	$0.72	+95.7%	$0.37	+224.0%	$-0.30	+85.5%	$-2.05	+20.8%	$-2.59	+71.2%	$-8.99	+51.9%	$-18.69	+64.0%	$-51.90	+68.7%	$-165.80	+97.3%	$-6210.35	-572.6%	$1314.05	-84.7%	$8579.18	+16775.8%	$50.84

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

Dividend History

$0.00

Atlas Lithium has not paid dividends over the past decade.

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Frequently Asked Questions

Why hold Atlas Lithium ATLX ADR instead of local B3 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is Atlas Lithium listed?

Atlas Lithium trades on a single exchange: NASDAQ in the United States (ATLX, US dollars). That is the line quoted on this page.

What is Atlas Lithium's primary listing?

Atlas Lithium's primary listing is on NASDAQ in the United States, where it trades as ATLX in US dollars — the line quoted on this page. It has no directly listed share on Brazil’s B3.

How can I buy Atlas Lithium stock in the United States?

Atlas Lithium is listed on the NASDAQ under ATLX, priced in US dollars. Any US brokerage offering NASDAQ-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 14, 17:00 BRT · Market closed

Financial data last updated: August 9, 2026

← All stocks & ETFs